Skip to main content
TipRanks
Go Ultimate75% OFF

Scott Rocklage Insider Profile

4 Followers

Scott Rocklage, Director at Aprea Therapeutics, holds 75.97K shares in Aprea Therapeutics (Ticker: APRE), holds 50.41K shares in Cidara Therapeutics (Ticker: CDTX), holds 2.55M shares in Epirus Biopharma (Ticker: EPRSQ). Most recently, Scott Rocklage Sold ― shares of Aprea Therapeutics on Jun 18, 2020 for an estimated value of $4.00M.

Scott Rocklage's Trading History

APRE
Aprea Therapeutics
Jun 18, 2020DirectorInformative Sell4.00M$30.84K
CDTX
Cidara Therapeutics
Apr 22, 2015―Uninformative Buy―$11.16M
EPRSQ
Epirus Biopharma
Feb 06, 2015―Informative Buy2.00M$1.27M
RLYP
Relypsa Inc
Nov 20, 2013―Uninformative Sell2.43K$1.02M
AKAOQ
Achaogen
―――$0.00

You May Also Like

Scott Rocklage insider profile FAQ

What is the percentage of profitable transactions made by Scott Rocklage?
The percentage of profitable transactions made by Scott Rocklage is 80%.
What is the average return per transaction made by Scott Rocklage?
The average return per transaction made by Scott Rocklage is 204.50%.
What stocks does Scott Rocklage hold?
Scott Rocklage holds: APRE, CDTX, EPRSQ, RLYP, AKAOQ stocks.
What was Scott Rocklage’s latest transaction?
Scott Rocklage’s latest transaction was an Informative Sell of $4.00M.
What was Scott Rocklage's most profitable transaction?
Scott Rocklage’s most profitable transaction was an Informative Buy of CDTX stock on April 14, 2015. The return on the trade was 800.00%.
What is Scott Rocklage's role in Aprea Therapeutics?
Scott Rocklage's role in Aprea Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.